NCT03673696

The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects

A Phase I, Single-center, Randomized，Double-blind, Placebo-controlled, Single & Multiple Ascending Dose Study to Assess the Tolerability and Pharmacokinetics of HEC74647PA Capsule in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 105 (actual)
• Sponsor: Sunshine Lake Pharma Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects

Detailed description

A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Single \& Multiple Ascending Dose Study to Access the Tolerability and Pharmacokinetics of HEC74647PA Capsule in Healthy Adult Subjects.

Conditions

• Chronic Hepatitis c

Interventions

Type	Name	Description
DRUG	HEC74647PA Capsule	Capsule administered orally once daily
DRUG	placebo	Matching Placebo Capsule

Timeline

• Start date: 2018-09-04
• Primary completion: 2019-07-02
• Completion: 2019-07-05
• First posted: 2018-09-17
• Last updated: 2020-03-19

Locations

1 site across 1 country: China